Drug Research
Germany – Taking Right Steps Towards Pharma Drugs Reshoring
As part of its endeavors to throttle the pharma sector domestically, the German government has gone ahead with the adoption of a strategy paper in December 2023, which identified three major areas that need to be strengthened.
The objectives include...
Drug Research
Green Chemistry Innovations Key To Pharma Solvent Sector
The pharmaceutical solvents sector has gone on to secure a valuation worth $3.9 billion in 2023 and is all set to scale the $6 billion mark by 2033 with a CAGR of 4.6% throughout the forecast period.
Let us have...
Drug Research
Inside Out of The Pharmaceutical Fine Chemicals Segment
The pharmaceutical fine chemicals market is all set to showcase significant growth, with an increase from $136 billion in 2024 to an expected $233 billion by 2031. This surge is going to be driven by a CAGR of 8%...
Drug Research
Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
Roche announced that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional collaboration. Bringing together the companies' expertise and track record in diagnostics innovation, engineering and manufacturing, the renewed contract further strengthens...
Drug Research
FDA Grants Roche Tina-qant Lp Assay Breakthrough Device Designation – a key marker for hereditary cardiovascular risk
Roche announced that the Tina-quant® lipoprotein Lp(a) RxDx assay has received Breakthrough Device Designation from the U.S. FDA to identify patients who may benefit from innovative Lp(a)-lowering therapy currently in development. Lp(a) is emerging as an important, yet under-recognised,...
Drug Research
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines
Eli Lilly and Company announced that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the company's total investment in this site from $3.7 billion to $9 billion. This expansion will...
Drug Research
Novo Nordisk invests ¥4 B in China for sterile preparation expansion project
Novo Nordisk has announced that it would invest approximately 4 billion yuan (¥) in Tianjin for a sterile preparation expansion project and recently held a groundbreaking ceremony for the expansion project.
On the day of the event, leaders from the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
